Subacute dopa-responsive Parkinsonism after successful surgical treatment of aqueductal stenosis.
Kinugawa
Kiyoka
K
Itti
Emmanuel
E
Lepeintre
Jean-Francois
JF
Mari
Ivan
I
Czernecki
Virginie
V
Heran
Francoise
F
Clemenceau
Stephane
S
Vidailhet
Marie
M
Roze
Emmanuel
E
D014150:Antipsychotic Agents / Q000008:administration & dosage*; D002535:Cerebral Aqueduct / Q000473:pathology*; D003251:Constriction, Pathologic / Q000150:complications; D006801:Humans; D006849:Hydrocephalus / Q000150:complications* / Q000000981:diagnostic imaging / Q000209:etiology* / Q000473:pathology / Q000601:surgery; D007279:Injections, Subcutaneous / Q000379:methods; D007980:Levodopa / Q000008:administration & dosage*; D008279:Magnetic Resonance Imaging / Q000379:methods; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods; D014326:Tropanes
D014150:Antipsychotic Agents; D014326:Tropanes; C087552:2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane; D007980:Levodopa